NVO - NOVO NORDISK A S

QQQ $ 633.20 nm (nm)

DIA $ 475.83 $ -1.36 (-0.29 %)

SPY $ 684.43 nm (nm)

TLT $ 90.42 nm (nm)

GLD $ 371.67 $ 7.13 (1.96 %)

Previous Close

$ 51.37

Open

$ 49.61

Bid

$ 50.40 x 107

Ask

$ 50.49 x 81

Day's Range

$ 49.44 - $ 50.54

52 Week Range

$ 44.55 - $ 110.64

Volume

21,057,534

Average Volume

Market Cap

225.68B

Beta (5Y Monthly)

$ 0.78

PE Ratio (TTM)

$ 16.10

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.03)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

eli-lilly-extends-lead-in-150b-obesity-drug-race-as-novo-pfizer-clash--heres-how-etfs-stand-to-gain

Eli Lilly Extends Lead In $150B Obesity Dr...
10/30/2025 20:04:44

As Eli Lilly, Novo Nordisk, and Pfizer battle for dominance in the obesity-drug market, these ETFs are offering exposure to the...

'Pfizer mulls suing Metsera, Novo over top...
10/30/2025 17:38:35

https://www.semafor.com/article/10/30/2025/pfizer-mulls-suing-metsera-novo-over-topping-bid

10 Health Care Stocks Whale Activity In To...
10/30/2025 17:35:24

pfizer-blasts-novo-nordisks-9-billion-counteroffer-for-metsera-as-reckless

Pfizer Blasts Novo Nordisk's $9 Billion Co...
10/30/2025 15:39:34

Novo Nordisk's $9 billion offer for Metsera challenges Pfizer's existing merger deal, prompting sharp criticism and pot...

Novo Nordisk Says Our Proposal Offers Comp...
10/30/2025 13:44:06

- Reuters

Pfizer Deems Novo Nordisk's Metsera Propos...
10/30/2025 11:19:57

Pfizer Inc. (NYSE:PFE) is aware of the reckless and unprecedented proposal by Novo Nordisk A/S (NYSE:NVO) to acquire Metsera, I...

Novo Nordisk Confirms That It Submitted An...
10/30/2025 09:59:13

P/E Ratio Insights for Novo Nordisk
10/24/2025 21:01:33

options-corner-a-reliable-quant-signal-just-flashed-again-for-pharma-giant-novo-nordisk

Options Corner: A Reliable Quant Signal Ju...
10/23/2025 20:32:29

While Novo Nordisk has been victimized by broader market pressure, NVO stock has just flashed a reliable quant signal for bulli...

eccogene-eyes-hong-kong-ipo-with-experimental-weight-loss-drug-astrazeneca-partnership

Eccogene Eyes Hong Kong IPO With Experimen...
10/23/2025 13:22:01

weight-loss-drugs-are-quietly-exploding-employer-health-insurance-costs-there-is-a-quiet-alarm-bell-going-off

Weight Loss Drugs Are Quietly Exploding Em...
10/23/2025 06:30:19

Employer-sponsored health insurance costs rise for third year, with average family premiums at $27,000 in 2025. Drug costs and ...

marjorie-taylor-greene-buys-6-stocks-and-bitcoin-etf-heres-her-latest-shopping-list

Marjorie Taylor Greene Buys 6 Stocks And B...
10/22/2025 21:52:46

Congresswoman Marjorie Taylor Greene (R-Ga.) is among the most active traders in Congress. Here's a look at her latest trad...

Novo Nordisk Foundation Proposes Lars Rebi...
10/21/2025 13:28:36

- Reuters

'Novo Chairman To Step Down Amid Wider Pla...
10/21/2025 12:46:35

https://www.bloomberg.com/news/articles/2025-10-21/novo-chairman-to-step-down-amid-wider-plan-to-shake-up-board?srnd=homepage-a...

Behind the Scenes of Novo Nordisk's Latest...
10/20/2025 14:05:10

no-place-is-risk-free-until-the-world-is-polio-free-bill-gates-urges-global-action-to-close-deadly-immunity-gaps

'No Place Is Risk-Free Until The World Is ...
10/19/2025 07:37:01

Polio cases drop 99.9%, but funding shortfall could undo progress. Last mile hardest as virus exploits immunity gaps.

benzinga-bulls-and-bears-stellantis-papa-johns-oklo--and-trade-tensions-shake-chip-stocks

Benzinga Bulls And Bears: Stellantis, Papa...
10/18/2025 11:41:17

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our t...

FDA Approves Novo Nordisk's Oral Semagluti...
10/17/2025 21:21:17

https://www.prnewswire.com/news-releases/fda-approves-novo-nordisks-oral-semaglutide-for-cardiovascular-cv-risk-reduction-in-ad...

trumps-weight-loss-drug-push-may-put-these-etfs-on-a-diet

Trump's Weight-Loss Drug Push May Put Thes...
10/17/2025 20:13:54

Trump's vow to slash weight-loss drug prices sent Hims & Hers tumbling. These ETFs are facing new pressure.

trump-induced-volatility-aside-novo-trades-cheap-while-patents-protect-its-profits-until-2032

Trump-Induced Volatility Aside, Novo Trade...
10/17/2025 18:33:22

Novo Nordisk offers cheap stock with strong moat and long-term growth tailwinds. Trump's drug price cut suggestion caused s...